Pancreatitis: Acute pancreatitis is thought to be a threat variable for GLP-1 medications. Tirzepatide has a comparable amount of hazard as GLP-1 agonist medications. If a affected individual receiving tirzepatide therapy encounters major abdominal pain, they need to be urged to visit their community crisis room for treatment. Some individuals may